Type 2 & other diabetes

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study

DiabetologiaPublished Cross-sectional study

Authors' conclusion

AGE accumulation was independently associated with prevalent heart failure. Among individuals free of heart failure, AGEs were associated with cardiac function, in particular systolic function. This association was present in participants with and without diabetes and was more prominent in those with diabetes.

Study context

Population
Participants of the population-based Rotterdam Study; Left ventricular (LV) function analyses among individuals free of HF (N=2362)2,362 free of HF
Participants
2,426 participants
Exposure
Higher vs lower skin autofluorescence, per one unit
Outcome
Prevalent HF
Methodological detailspopulation-based, adjusted for traditional cardiovascular risk factors
  • Population-based
  • Adjusted for traditional cardiovascular risk factors

Main finding

As reported in the abstract

Prevalent HF, per one unit higher SAF

Multivariable adjusted OR per one unit higher skin autofluorescence (SAF)

OR 2.90

95% CI 1.80, 4.62

Observational data: associations, not effects.

Further findings

LV ejection fraction per one unit increase in SAF, individuals without HF

Mean difference (β)
−0.98% (95% CI −1.45%, −0.50%)

LV ejection fraction per one unit increase in SAF, by diabetes status

With diabetes, β
−1.84% (95% CI −3.10%, −0.58%)
Without diabetes, β
−0.78% (95% CI −1.29%, −0.27%)
  • Association stronger among participants with diabetes

Diastolic function parameters

Associations of SAF with diastolic function parameters not apparent, except in men with diabetes

Original publication

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study. Diabetologia. Published 8 November 2022. doi:10.1007/s00125-022-05821-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.